RBP4 and metabolic dysfunction-associated steatotic liver disease: While several observational studies have reported elevated serum levels of other obesity-related adipokines, such as resistin, visfatin, and RBP4 in NAFLD patients, some contradictory results have also been reported, suggesting that the causal relationship between these adipokines and NAFLD remains under debate [91,92].